arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Atrium Therapeutics, Inc.

RNA Health Care Biotechnology: Pharmaceutical Preparations
$8.20
▲ +2.5% Today
as of Oct 23, 16:51 ET
Last 30 days -19.69% Sep 14 → Oct 23
$7.40 $8.16 $8.91 $9.66 $10.42 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$8.06
High
$8.21
Low
$7.79
Volume
$192,644
Avg Vol
$416,259
Mkt Cap
$210M
P/E (TTM)
—
Beta
—
52w High
$16.77
52w Low
$7.49
Div Yield
—
Shares Out
$17M

Recent Press Releases & News last 60 days · 8 items

Oct 22 · 12:16 MT Newswires
Roth Capital Initiates Atrium Therapeutics at Buy
Oct 20 · 21:23 PR PR Newswire
Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Oct 20 · 12:09 PR PR Newswire
Yakira Capital Management Calls on Atrium Therapeutics to Launch Strategic Review, Curb Cash Spending and Explain Dilutive Financing
▸ Show all 8 press releases & news Free account →

RNA earnings at a glance

The options market is pricing a move of about ±1283.3% after the report, a range of roughly -$97.03 to $113.43 from today's $8.20. Over its last 1 reports the stock rose the next day 0 times and fell 1, moving ±0.2% on average; after the most recent report on May 14, 2026 it moved -0.2%. That means options currently expect more movement than RNA has typically delivered. Implied volatility is currently 36%. The share price of $8.20 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$7.49
$17
8% of range
Avg surprise (last 0)
—
Avg reaction (last 1)
-0.2%
0% positive
Latest IV / EM
3647%
EM ±1283.3% · $20 · Dec 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.18$-0.99$-0.81$-0.62$-0.44 Actual $-0.44Actual $-0.75Actual $-0.97Actual $-1.18 MarJunMar/2026Jun
Revenue vs Net Income Revenue Net income
$-20M$-10M$215,375$10M$21M Mar 25Jun 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-1.18 — — — — financials
Thu May 14, 2026Mar/2026 $-0.97 — — — -0.2% earnings
Mon Jun 30, 2025Jun 2025 $-0.75 — — — — financials
Mon Mar 31, 2025Mar 2025 $-0.44 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Jun 2025Mar 2025
Revenue$3M$20M—$4M$2M
Cost of revenue—————
Gross profit—————
Operating income$-23M$-17M—$-13M$-7M
Net income$-20M$-17M—$-13M$-7M
EPS (diluted)$-1.18$-0.97—$-0.75$-0.44

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Jun 2025Mar 2025
Cash & equivalents$72M$268M$0$0$0
Inventory—————
Total current assets$275M$286M$3M——
Total assets$281M$292M$8M——
Long-term debt—————
Total liabilities$66M$58M$71M——
Total equity$215M$234M$-63M$-56M$-56M

Implied volatility — last 90 days

2085%8201%14317%20433%26549% Jun 08 — IV 6949% · EM ±917.7%Jun 09 — IV 7201% · EM ±902.2%Jun 10 — IV 7689% · EM ±908.3%Jun 11 — IV 7725% · EM ±853.6%Jun 12 — IV 8384% · EM ±857.7%Jun 15 — IV 11602% · EM ±839.2%Jun 16 — IV 14088% · EM ±832.0%Jun 17 — IV 20549% · EM ±858.2%Jun 19 — IV 2121% · EM ±845.2%Jun 22 — IV 2113% · EM ±827.7%Jun 23 — IV 2144% · EM ±835.3%Jun 24 — IV 2153% · EM ±834.0%Jun 25 — IV 2174% · EM ±837.2%Jun 26 — IV 2150% · EM ±823.1%Jun 29 — IV 2086% · EM ±783.9%Jun 30 — IV 2132% · EM ±796.3%Jul 01 — IV 2167% · EM ±804.5%Jul 02 — IV 2125% · EM ±783.9%Jul 03 — IV 2139% · EM ±783.9%Jul 06 — IV 2291% · EM ±823.2%Jul 07 — IV 2267% · EM ±808.9%Jul 08 — IV 2258% · EM ±800.3%Jul 09 — IV 2355% · EM ±828.8%Jul 10 — IV 2458% · EM ±858.7%Jul 13 — IV 2561% · EM ±875.6%Jul 14 — IV 2557% · EM ±867.4%Jul 15 — IV 2558% · EM ±861.2%Jul 16 — IV 2612% · EM ±872.5%Jul 17 — IV 2632% · EM ±872.4%Jul 20 — IV 2789% · EM ±902.2%Jul 21 — IV 2689% · EM ±862.5%Jul 22 — IV 2738% · EM ±871.0%Jul 23 — IV 2823% · EM ±890.0%Jul 24 — IV 2952% · EM ±922.5%Jul 27 — IV 3016% · EM ±917.0%Jul 28 — IV 3063% · EM ±922.5%Jul 29 — IV 3118% · EM ±929.8%Jul 30 — IV 3135% · EM ±925.8%Jul 31 — IV 3198% · EM ±934.8%Aug 03 — IV 3306% · EM ±936.5%Aug 04 — IV 3279% · EM ±918.5%Aug 05 — IV 3259% · EM ±902.9%Aug 06 — IV 3199% · EM ±876.1%Aug 07 — IV 3177% · EM ±859.8%Aug 10 — IV 3324% · EM ±866.8%Aug 11 — IV 3387% · EM ±872.0%Aug 12 — IV 3429% · EM ±871.0%Aug 13 — IV 3463% · EM ±867.8%Aug 14 — IV 3352% · EM ±828.3%Aug 17 — IV 3495% · EM ±825.6%Aug 18 — IV 3584% · EM ±833.3%Aug 19 — IV 3412% · EM ±780.5%Aug 20 — IV 3529% · EM ±793.8%Aug 21 — IV 3668% · EM ±810.6%Aug 24 — IV 3762% · EM ±785.6%Aug 25 — IV 3736% · EM ±764.3%Aug 26 — IV 3857% · EM ±772.6%Aug 27 — IV 3907% · EM ±765.4%Aug 28 — IV 4099% · EM ±784.5%Aug 31 — IV 4534% · EM ±803.3%Sep 01 — IV 4513% · EM ±777.1%Sep 02 — IV 4556% · EM ±761.0%Sep 03 — IV 4531% · EM ±732.9%Sep 04 — IV 4826% · EM ±754.1%Sep 07 — IV 5444% · EM ±754.1%Sep 08 — IV 7183% · EM ±948.6%Sep 09 — IV 8050% · EM ±1008.6%Sep 10 — IV 8603% · EM ±1016.2%Sep 11 — IV 9260% · EM ±1023.2%Sep 14 — IV 12430% · EM ±1038.2%Sep 15 — IV 14523% · EM ±1050.5%Sep 16 — IV 18892% · EM ±1115.8%Sep 17 — IV 26549% · EM ±1108.8%Sep 21 — IV 2944% · EM ±1153.4%Sep 22 — IV 2951% · EM ±1149.7%Sep 23 — IV 3286% · EM ±1272.5%Sep 24 — IV 3361% · EM ±1294.3%Sep 25 — IV 3341% · EM ±1278.6%Sep 28 — IV 3349% · EM ±1258.9%Sep 29 — IV 3370% · EM ±1258.9%Sep 30 — IV 3449% · EM ±1280.2%Oct 01 — IV 3531% · EM ±1302.2%Oct 02 — IV 3689% · EM ±1352.0%Oct 06 — IV 3718% · EM ±1326.7%Oct 07 — IV 3772% · EM ±1336.7%Oct 08 — IV 3647% · EM ±1283.3%

Sector peers

SION
Sionna Therapeutics, Inc.
$218M $3.60-7.0%
NATR
Nature's Sunshine Products, Inc.
$222M $12.15-0.9%
KROS
Keros Therapeutics, Inc.
$222M $11.28+0.9%
WHWK
Whitehawk Therapeutics, Inc.
$194M $3.21-2.3%
PRQR
ProQR Therapeutics N.V.
$230M $1.29-5.8%
SIGA
SIGA Technologies Inc.
$234M $3.120.0%

RNA earnings FAQ

What is RNA's expected move for earnings?

Options currently price a move of about ±1283.3%, or $105.23 per share either way from $8.20.

How does RNA stock usually react to earnings?

Across the last 1 reports the average next-day move was ±0.2%, up 0 times and down 1 times.

What is RNA's implied volatility?

RNA's at-the-money implied volatility is about 36% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in